Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Capricor Therapeutics (CAPR) Debt Ratio (2016 - 2024)

Capricor Therapeutics (CAPR) has 14 years of Debt Ratio data on record, last reported at 0.04 in Q3 2024.

  • For Q3 2024, Debt Ratio fell 60.03% year-over-year to 0.04; the TTM value through Sep 2024 reached 0.04, down 60.03%, while the annual FY2023 figure was 0.06, 16.91% down from the prior year.
  • Debt Ratio reached 0.04 in Q3 2024 per CAPR's latest filing, down from 0.09 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.24 in Q1 2020 and bottomed at 0.0 in Q4 2020.
  • Average Debt Ratio over 5 years is 0.07, with a median of 0.07 recorded in 2022.
  • Peak YoY movement for Debt Ratio: plummeted 99.32% in 2020, then skyrocketed 4559.3% in 2021.
  • A 5-year view of Debt Ratio shows it stood at 0.0 in 2020, then surged by 4559.3% to 0.1 in 2021, then dropped by 28.08% to 0.07 in 2022, then dropped by 16.91% to 0.06 in 2023, then crashed by 36.81% to 0.04 in 2024.
  • Per Business Quant database, its latest 3 readings for Debt Ratio were 0.04 in Q3 2024, 0.09 in Q2 2024, and 0.07 in Q1 2024.